APA (7th ed.) Citation

SCHERNTHANER, G., GROSS, J. L., ROSENSTOCK, J., GUARISCO, M., FU, M., YEE, J., . . . MEININGER, G. (2013). Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial. Diabetes care, 36(9), 2508-2515. https://doi.org/10.2337/dc12-2491

Chicago Style (17th ed.) Citation

SCHERNTHANER, Guntram, Jorge L. GROSS, Julio ROSENSTOCK, Michael GUARISCO, MIN FU, Jacqueline YEE, Masato KAWAGUCHI, William CANOVATCHEL, and Gary MEININGER. "Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week Randomized Trial." Diabetes Care 36, no. 9 (2013): 2508-2515. https://doi.org/10.2337/dc12-2491.

MLA (9th ed.) Citation

SCHERNTHANER, Guntram, et al. "Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week Randomized Trial." Diabetes Care, vol. 36, no. 9, 2013, pp. 2508-2515, https://doi.org/10.2337/dc12-2491.